top of page
prof.-dr_edited.jpg

Yayınlar

Araştırma ve Yazma
IMG_7002.jpg

1)Interference in scientific research on COVID-19 in Turkey

Hasan Bayram, Nurdan Köktürk, Osman Elbek, Oğuz Kılınç, Abdullah Sayıner, Elif Dağlı, Turkish Thoracic

Society Lancet. 2020 15-21 August; 396(10249): 463–464.  

 

2)European Respiratory Society International Congress 2018: four shades of epidemiology and tobacco

control

Maaike de Vries, Eleanor L. Axson, Jate Ratanachina, Orianne Dumas, Sara De Matteis, Annabelle Bédard,

Célina Roda, Subhabrata Moitra, Elif Dagli, Athina Dimanti, Asli Gorek Dilektasli, Sofia Ravara, André F.S.

Amaral

ERJ Open Res. 2019 Feb; 5(1): 00217-2018. 

 

3)ERS and tobacco harm reduction.” Charlotta Pisinger, Elif Dagli, Filippos T. Filippidis, Linnea Hedman,

Christer Janson, Stelios Loukides, Sofia Ravara, Isabel Saraiva and Jørgen Vestbo, the ERS Tobacco

Control Committee, on behalf of the ERS. Eur Respir J 2019; 54: 1902009.

 

4)Extensive Exposure to Tear Gases in Ankara

Aslıhan Ilgaz, Filiz Çağla Küçük Uyanusta, Peri Arbak, Arif Müezzinoğlu, Tansu Ulukavak Çiftçi, Serdar

Akpınar, Hikmet Fırat, Selma Fırat Güven, Bülent Çiftçi, Selen Karaoğlanoğlu, Elif Dağlı, Feyza Erkan Turk

Thorac J. 2019 Apr; 20(2): 108–113. 

 

5)Tobacco Control in Turkey

Osman Elbek, Oğuz Kılınç, Zeynep Ayfer Aytemur, Levent Akyıldız, Çağla Uyanusta Küçük, Cengiz Özge, Leyla Sağlam, Pınar Bostan, Elif Dağlı

Turk Thorac J. 2015 Jul; 16(3): 141–150.

6)Noncompliance to smoke-free law: which hospitality premises are more prone? Ay P, Evrengil E, Guner M, Dagli E. Public Health. 2016 Dec;141:1-6. doi: 10.1016/j.puhe.2016.08.008.

 

7) Oral health and related factors in a group of children with cystic fibrosis in Istanbul, Turkey.

Peker S, Kargul B, Tanboga I, Tunali-Akbay T, Yarat A, Karakoc F, Ersu R, Dagli E.

Niger J Clin Pract. 2015 Jan-Feb;18(1):56-60. doi: 10.4103/1119-3077.146980.

 

8) Multicentric analysis of childhood tuberculosis in Turkey.

Pekcan S, Tana Aslan A, Kiper N, Uysal G, Gürkan F, Patıroğlu T, Oztürk M, Ozen M, Dağlı E, Doğru U, Kocabaş E, Sarısoy O, Koçak A, Uzuner N, Reisli I, Bolat A, Uğuz A, Karakelleoğlu C, Uyan A, Köse M, Cinel G, Cobanoğlu N, Yalçın E, Doğru D, Ozçelik U.

Turk J Pediatr. 2013 Mar-Apr;55(2):121-9.

 

9) An unusual case of childhood sarcoidosis: an unusual clinical case.

Gokdemir Y, Ersu R, Karadag B, Karakoc F, Kiyan G, Kaya H, Kasapcopur O, Erdem E, Dagli E.

Arch Argent Pediatr. 2013 Oct;111(5):441-5.

 

10) Sleep disordered breathing in patients with primary ciliary dyskinesia.

Oktem S, Karadag B, Erdem E, Gokdemir Y, Karakoc F, Dagli E, Ersu R.

Pediatr Pulmonol. 2013 Sep;48(9):897-903.

 

11) Effect of night symptoms and disease severity on subjective sleep quality in children with non-cystic-fibrosis bronchiectasis.

Erdem E, Ersu R, Karadag B, Karakoc F, Gokdemir Y, Ay P, Akpinar IN, Dagli E.

Pediatr Pulmonol. 2011 Sep;46(9):919-26.

 

12) The prevalence and risk factors of asthma and allergic diseases among working adolescents.

Cakir E, Ersu R, Uyan ZS, Oktem S, Varol N, Karakoc F, Karadag B, Akyol M, Dagli E.

Asian Pac J Allergy Immunol. 2010 Jun-Sep;28(2-3):122-

 

13) Sudden infant death syndrome: how much mothers and health professionals know.

Yikilkan H, Unalan PC, Cakir E, Ersu RH, Cifcili S, Akman M, Uzuner A, Dagli E.

Pediatr Int. 2011 Feb;53(1):24-8.

 

14) Invasive respiratory aspergillosis is a treatable disease with early diagnosis and aggressive therapy.

Cakir FB, Cakir E, Berrak SG, Uyan ZS, Canpolat C, Karakoc F, Dagli E.

Pediatr Hematol Oncol. 2010 Sep;27(6):422-34.

 

15) Diaphragmatic paralysis after pediatric heart surgery: usefulness of non-invasive ventilation.

Oktem S, Cakir E, Uyan ZS, Karadag B, Hamutcu RE, Kiyan G, Akalin F, Karakoc F, Dagli E.

Int J Pediatr Otorhinolaryngol. 2010 Apr;74(4):430-1.

 

16) Mycobacterium abscessus infection in a cystic fibrosis patient: a difficult to treat infection.

Uyan ZS, Ersu R, Oktem S, Cakir E, Koksalan OK, Karadag B, Karakoc F, Dagli E.

Int J Tuberc Lung Dis. 2010 Feb;14(2):250-1.

 

 

17) Flexible bronchoscopy as a valuable tool in the evaluation of persistent wheezing in children.

Cakir E, Ersu RH, Uyan ZS, Oktem S, Karadag B, Yapar O, Pamukcu O, Karakoc F, Dagli E.

Int J Pediatr Otorhinolaryngol. 2009 Dec;73(12):1666-8.

 

18) Foreign body aspiration in children: the value of diagnostic criteria.

Kiyan G, Gocmen B, Tugtepe H, Karakoc F, Dagli E, Dagli TE.

Int J Pediatr Otorhinolaryngol. 2009 Jul;73(7):963-7.

 

 

19) Effect of occupation and smoking on respiratory symptoms in working children.

Cakir E, Uyan ZS, Varol N, Ay P, Ozen A, Karadag B, Ersu R, Karakoc F, Dagli E.

Am J Ind Med. 2009 Jun;52(6):471-8.

 

20) The prevalence of headache and its association with socioeconomic status among schoolchildren in istanbul, Turkey.

Işik U, Topuzoğlu A, Ay P, Ersu RH, Arman AR, Onsüz MF, Karavuş M, Dagli E.

Headache. 2009 May;49(5):697-703. doi: 10.1111/j.1526-4610.2009.01339.x. Epub 2009 Jan 21.

 

21) Withdrawal of inhaled steroids in children with non-cystic fibrosis bronchiectasis.

Guran T, Ersu R, Karadag B, Karakoc F, Demirel GY, Hekim N, Dagli E.

J Clin Pharm Ther. 2008 Dec;33(6):603-11.

 

22) Flexible bronchoscopy for diagnosis and follow up of childhood endobronchial tuberculosis.

Cakir E, Uyan ZS, Oktem S, Karakoc F, Ersu R, Karadag B, Dagli E.

Pediatr Infect Dis J. 2008 Sep;27(9):783-7.

 

23) An unusual case of chylothorax complicating childhood tuberculosis.

Cakir E, Gocmen B, Uyan ZS, Oktem S, Kiyan G, Karakoc F, Ersu R, Karadag B, Dagli T, Dagli E.

Pediatr Pulmonol. 2008 Jun;43(6):611-4. doi:

 

24)Efficacy of salbutamol and ipratropium bromide in the management of acute bronchiolitis--a clinical trial.

Karadag B, Ceran O, Guven G, Dursun E, Ipek IO, Karakoc F, Ersu RH, Bozaykut A, Inan S, Dagli E.

Respiration. 2008;76(3):283-7.

 

25) Home ventilation for children with chronic respiratory failure in Istanbul.

Oktem S, Ersu R, Uyan ZS, Cakir E, Karakoc F, Karadag B, Kiyan G, Dagli E.

Respiration. 2008;76(1):76-81. Epub 2007 Nov 6.

 

 

26) Quantitative analysis of ciliary ultrastructure in patients with primary ciliary dyskinesia.

Sirvanci S, Seda Uyan Z, Ercan F, Karadag B, Ersu R, Karakoc F, Dagli E, San T.

Acta Histochem. 2008;110(1):34-41.

 

27) Bone mineral density in children with non-cystic fibrosis bronchiectasis.

Guran T, Turan S, Karadag B, Ersu R, Karakoc F, Bereket A, Dagli E.

Respiration. 2008;75(4):432-6.

 

 

 

28) Factors that correlate with sleep oxygenation in children with cystic fibrosis.

Uyan ZS, Ozdemir N, Ersu R, Akpinar I, Keskin S, Cakir E, Karadağ B, Karakoç F, Dağli E.

Pediatr Pulmonol. 2007 Aug;42(8):716-22.

 

29) Is childhood asthma still underdiagnosed and undertreated in Istanbul?

Karadag B, Karakoc F, Ersu R, Dagli E.

Pediatr Int. 2007 Aug;49(4):508-12.

 

30) Prevalence of headache and its association with sleep disorders in children.

Isik U, Ersu RH, Ay P, Save D, Arman AR, Karakoc F, Dagli E.

Pediatr Neurol. 2007 Mar;36(3):146-51.

 

31) Association between inflammatory markers in induced sputum and clinical characteristics in children with non-cystic fibrosis bronchiectasis.

Guran T, Ersu R, Karadag B, Akpinar IN, Demirel GY, Hekim N, Dagli E.

Pediatr Pulmonol. 2007 Apr;42(4):362-9.

 

32) Tracheobronchial calcification associated with Keutel syndrome.

Ozdemir N, Ersu R, Akalin F, Karadag B, Kut A, Karakoç F, Elçioglu N, Dagli E.

Turk J Pediatr. 2006 Oct-Dec;48(4):357-61.

 

33) Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy.

Tønnesen P, Carrozzi L, Fagerström KO, Gratziou C, Jimenez-Ruiz C, Nardini S, Viegi G, Lazzaro C, Campell IA, Dagli E, West R.

Eur Respir J. 2007 Feb;29(2):390-417. Review.

 

34) Late diagnosis of foreign body aspiration in children with chronic respiratory symptoms.

Karakoc F, Cakir E, Ersu R, Uyan ZS, Colak B, Karadag B, Kiyan G, Dagli T, Dagli E.

Int J Pediatr Otorhinolaryngol. 2007 Feb;71(2):241-6. Epub 2006 Nov 27.

 

35) Mucoid impaction: an unusual form of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis.

Cakir E, Uyan ZS, Ersu RH, Karadag B, Karakoc F, Dagli E.

Pediatr Pulmonol. 2006 Nov;41(11):1103-7.

36) Treatment outcome of asthma after one year follow-up in health centres of several developing countries.

Aït-Khaled N, Enarson DA, Bencharif N, Boulahdib F, Camara LM, Dagli E, Karadag B, Ottmani SE, Pham DL, Sow O, Yousser M, Zidouni N.

Int J Tuberc Lung Dis. 2006 Aug;10(8):911-6. Erratum in: Int J Tuberc Lung Dis. 2006 Nov;10(11):1304.

 

 

37) Cardiac echinococcosis with intra-atrial localization.

Altun O, Akalin F, Ayabakan C, Karadağ B, Berrak SG, Bilal MS, Ozek E, Dagli E.

Turk J Pediatr. 2006 Jan-Mar;48(1):76-9.

 

38) Implementation of asthma guidelines in health centres of several developing countries.

Aït-Khaled N, Enarson DA, Bencharif N, Boulahdib F, Camara LM, Dagli E, Djankine TK, Keita B, Karadag B, Ngoran K, Odhiambo J, Ottmani SE, Pham DL, Sow O, Yousser M, Zidouni N.

Int J Tuberc Lung Dis. 2006 Jan;10(1):104-9.

 

39) Non cystic fibrosis bronchiectasis.

Dagli E.

Paediatr Respir Rev. 2000 Mar;1(1):64-70. Review.

 

40) Symptoms of inattention and hyperactivity in children with habitual snoring: evidence from a community-based study in Istanbul.

Arman AR, Ersu R, Save D, Karadag B, Karaman G, Karabekiroglu K, Karakoc F, Dagli E, Berkem M.

Child Care Health Dev. 2005 Nov;31(6):707-17.

 

41) Influence of social environment in smoking among adolescents in Turkey.

Erbaydar T, Lawrence S, Dagli E, Hayran O, Collishaw NE.

Eur J Public Health. 2005 Aug;15(4):404-10

 

42) Early pulmonary involvement in Niemann-Pick type B disease: lung lavage is not useful.

Uyan ZS, Karadağ B, Ersu R, Kiyan G, Kotiloğlu E, Sirvanci S, Ercan F, Dagli T, Karakoç F, Dagli E.

Pediatr Pulmonol. 2005 Aug;40(2):169-72.

 

43)Non-cystic-fibrosis bronchiectasis in children: a persisting problem in developing countries.

Karadag B, Karakoc F, Ersu R, Kut A, Bakac S, Dagli E.

Respiration. 2005 May-Jun;72(3):233-8.

 

44) Mucoepidermoid carcinoma of the bronchus: a rare entity in childhood.

Kut A, Karadag B, Karakoc F, Ersu R, Yildizeli B, Kotiloglu E, Yuksel M, Dagli E.

Pediatr Int. 2005 Apr;47(2):203-5.

 

45) Environmental influences on asthma and allergy.

Asher I, Dagli E.

Chem Immunol Allergy. 2004;84:36-101. Review.

 

46) World Allergy Organization guidelines for prevention of allergy and allergic asthma.

Asher I, Baena-Cagnani C, Boner A, Canonica GW, Chuchalin A, Custovic A, Dagli E, Haahtela T, Haus M, Lemmo-Hoten M, Holgate S, Holloway J, Holt P, Host A, Iikura Y, Johansson SG, Kaplan A, Kowalski ML, Lockey RF, Naspitz C, Odhiambo J, Ring J, Sastre J, Venables K, Vichyanond P, Volovitz B, Wahn U, Warner J, Weiss K, Zhong NS; World Allergy Organization.

Int Arch Allergy Immunol. 2004 Sep;135(1):83-92.

 

47) Prevalence of snoring and symptoms of sleep-disordered breathing in primary school children in istanbul.

Ersu R, Arman AR, Save D, Karadag B, Karakoc F, Berkem M, Dagli E.

Chest. 2004 Jul;126(1):19-24.

 

48) Does passive smoke exposure trigger acute asthma attack in children?

Karadag B, Karakoç F, Ceran O, Ersu R, Inan S, Dagli E.

Allergol Immunopathol (Madr). 2003 Nov-Dec;31(6):318-23.

 

49) Effects of childhood bronchiectasis on cardiac functions.

AkalIn F, Köroglŭ TF, Bakaç S, Dagli E.

Pediatr Int. 2003 Apr;45(2):169-74.

 

50) Paediatric respiratory training in Europe: syllabus and centres.

Zach MS; Long Range Planning Committee, Paediatric Assembly of the European Respiratory Society, Committee on Paediatric Respiratory Training in Europe, European Board of Paediatrics.

Eur Respir J. 2002 Dec;20(6):1587-93.

 

51) Highest heterogeneity for cystic fibrosis: 36 mutations account for 75% of all CF chromosomes in Turkish patients.

Kilinç MO, Ninis VN, Dagli E, Demirkol M, Ozkinay F, Arikan Z, Coğulu O, Hüner G, Karakoç F, Tolun A.

Am J Med Genet. 2002 Dec 1;113(3):250-7.

 

52) Foreign body aspiration: what is the outcome?

Karakoç F, Karadağ B, Akbenlioğlu C, Ersu R, Yildizeli B, Yüksel M, Dagli E.

Pediatr Pulmonol. 2002 Jul;34(1):30-6.

 

53) A comparison of the efficacy and safety of a half dose of fluticasone propionate with beclamethasone dipropionate and budesonide in childhood asthma.

Karakoç F, Karadag B, Kut A, Ersu R, Bakaç S, Cebeci D, Dagli E.

J Asthma. 2001 May;38(3):229-37.

 

54) Prevention of allergy and asthma: interim report.

Asher I, Boner A, Chuchalin A, Custovic A, Dagli E, Haus M, Hemmo-Lotem M, Holgate ST, Holt PG, Høst A, Iikura I, Johansson SG, Kowalski ML, Naspitz CK, Odhiambo J, Vichyanond P, Volovitz B, Wahn U, Warner JO, Weiss K, Zhong NS.

Allergy. 2000 Nov;55(11):1069-88.

 

 

55) The effect of passive smoking on the development of respiratory syncytial virus bronchiolitis.

Gürkan F, Kiral A, Dagli E, Karakoç F.

Eur J Epidemiol. 2000 May;16(5):465-8.

 

56) Tobacco industry tactics for resisting public policy on health.

Saloojee Y, Dagli E.

Bull World Health Organ. 2000;78(7):902-10. Review.

 

57) Genotype-phenotype correlation in three homozygotes for the cystic fibrosis mutation 2183AA-->G shows a severe phenotype.

Kilinç MO, Ninis VN, Tolun A, Estivill X, Casals T, Savov A, Dagli E, Karakoç F, Demirkol M, Hüner G, Ozkinay F, Demir E, Seculi JL, Pena J, Bousono C, Ferrer-Calvete J, Calvo C, Glover G, Kremenski I.

J Med Genet. 2000 Apr;37(4):307-9.

 

58) Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries.

Aït-Khaled N, Auregan G, Bencharif N, Camara LM, Dagli E, Djankine K, Keita B, Ky C, Mahi S, Ngoran K, Pham DL, Sow O, Yousser M, Zidouni N, Enarson DA.

Int J Tuberc Lung Dis. 2000 Mar;4(3):268-71.

 

59) Are low income countries targets of the tobacco industry? Plenary lecture given during the Conference on Global Lung Health and 1997 Annual Meeting of the International Union Against Tuberculosis and Lung Disease, Palais des Congrès, Paris, France, 1-4 October 1997. Dagli E.

Int J Tuberc Lung Dis. 1999 Feb;3(2):113-8.

 

60) Inhaler medicament effects on saliva and plaque pH in asthmatic children.

Kargul B, Tanboga I, Ergeneli S, Karakoc F, Dagli E.

J Clin Pediatr Dent. 1998 Winter;22(2):137-40.

 

61) Raised serum soluble interleukin-2 receptor concentrations in cystic fibrosis patients with and without evidence of lung disease.

Dagli E, Warner JA, Besley CR, Warner JO.

Arch Dis Child. 1992 Apr;67(4):479-81.

 

62) High-performance liquid chromatography method for serum methotrexate levels in children with severe steroid-dependent asthma. Assadullahi TP, Dagli E, Warner JO.

J Chromatogr. 1991 Apr 19;565(1-2):349-56.

 

63) Tuberculous meningitis in childhood

Tuncer AM, Kinik E, Dagli E, Tezcan I.

Mikrobiyol Bul. 1986 Jan;20(1):9-13. Turkish.

 

 

64) Effect of cimetidine on the course of measles

Tuncer AM, Teczan I, Dagli E, Kinik E.

Mikrobiyol Bul. 1985 Jan;19(1):1-8. Turkish.

 

65) Campylobacter jejuni gastroenteritis

Tezcan I, Ceyhan M, Diker S, Tuncer AM, Dagli E, Kinik E.

Mikrobiyol Bul. 1984 Jan;18(1):23-8. Turkish.

 

66) Potter's syndrome: bilateral renal agenesis (a report of two cases emphasizing associated malformations).

Tinaztepe K, Balci S, Tinaztepe B, Dagli E.

Turk J Pediatr. 1983 Jul-Sep;25(3):179-87. No abstract available.

bottom of page